These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 487808)

  • 21. Postpartum IUDS: keys for success.
    O'Hanley K; Huber DH
    Contraception; 1992 Apr; 45(4):351-61. PubMed ID: 1516367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two years' experience with two levonorgestrel-releasing intrauterine devices and one copper-releasing intrauterine device: a randomized comparative performance study.
    Nilsson CG; Allonen H; Diaz J; Luukkainen T
    Fertil Steril; 1983 Feb; 39(2):187-92. PubMed ID: 6401636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. One-year clinical experience with FlexiGard.
    Batar I
    Contraception; 1992 Oct; 46(4):307-12. PubMed ID: 1486769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Five years' experience with levonorgestrel-releasing IUDs.
    Luukkainen T; Allonen H; Haukkamaa M; Lähteenmäki P; Nilsson CG; Toivonen J
    Contraception; 1986 Feb; 33(2):139-48. PubMed ID: 3084167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immediate postpartum insertion of a copper-wired intrauterine contraceptive device, the MLCu250.
    Thiery M; Van Der Pas H; Delbeke L; Van Kets H
    Br J Obstet Gynaecol; 1979 Aug; 86(8):654-8. PubMed ID: 497136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of a progesterone-releasing intrauterine contraceptive device on endometrial blood vessels: a morphometric study.
    Shaw ST; Macaulay LK; Aznar R; González-Angulo A; Roy S
    Am J Obstet Gynecol; 1981 Dec; 141(7):821-7. PubMed ID: 7315908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A review of the use of intrauterine devices in nulliparous women.
    Graham S; Simcock BW
    Contraception; 1982 Oct; 26(4):323-46. PubMed ID: 6759026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of three different models of the copper T intrauterine contraceptive device.
    Roy S; Casagrande J; Cooper DL; Mishell DR
    Am J Obstet Gynecol; 1979 Jul; 134(5):568-74. PubMed ID: 453297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Contraception with the intrauterine pessary Progestasert].
    Schweppe KW; Tenhaeff D; Rache D
    Fortschr Med; 1978 Sep; 96(33):1685-90. PubMed ID: 700553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intrauterine contraception with Nova-T and copper-T-200 during three years.
    Nygren KG; Nielsen NC; Pyörälä T; Allonen H; Luukkainen T
    Contraception; 1981 Nov; 24(5):529-42. PubMed ID: 7032839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Twelve-month comparative multicenter study of the TCu 380A and ML 250 intrauterine devices in Bangkok, Thailand.
    Reinprayoon D; Gilmore C; Farr G; Amatya R
    Contraception; 1998 Oct; 58(4):201-6. PubMed ID: 9865999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selected events following insertion of the Progestasert system.
    Gibor Y; Mitchell C
    Contraception; 1980 May; 21(5):491-503. PubMed ID: 7428359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two-year rates for Nova T and Copper T in a comparative study.
    Allonen H; Luukkainen T; Nielsen NC; Nygren KG; Pyörälä T
    Contraception; 1980 Apr; 21(4):321-34. PubMed ID: 6993095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors affecting intrauterine contraceptive device performance. I. Endometrial cavity length.
    Hasson HM; Berger GS; Edelman DA
    Am J Obstet Gynecol; 1976 Dec; 126(8):973-81. PubMed ID: 998687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Levonorgestrel plasma concentrations and hormone profiles after insertion and after one year of treatment with a levonorgestrel-IUD.
    Nilsson CG; Lähteenmäki P; Luukkainen T
    Contraception; 1980 Mar; 21(3):225-33. PubMed ID: 6771090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Can intrauterine device removals for bleeding or pain be predicted at a one-month follow-up visit? A multivariate analysis.
    Stanback J; Grimes D
    Contraception; 1998 Dec; 58(6):357-60. PubMed ID: 10095972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effectiveness research of medicated γ intrauterine device and medicated genefix intrauterine device inserted immediately after abortion].
    Wang K; Cheng Y; Yang H; Tang YH; Jiang J; Ji F; Li LB; Wu SC
    Zhonghua Fu Chan Ke Za Zhi; 2016 Mar; 51(3):198-203. PubMed ID: 27030499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison between two IUDs: Progestasert and CuT 200.
    Larsen S; Hansen MK; Jacobsen JC; Ladehoff P; Sorensen T; Westergaard JG
    Contracept Deliv Syst; 1981 Oct; 2(4):281-6. PubMed ID: 12336988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Copper T 220C: a new long-acting copper intrauterine contraceptive device.
    Cooper DL; Millen AK; Mishell DR
    Am J Obstet Gynecol; 1976 Jan; 124(2):121-4. PubMed ID: 1247047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.